First-trimester Fasting Glycemia As a Predictor of Gestational Diabetes (GDM) and Adverse Pregnancy Outcomes
Overview
Affiliations
Aims: Studies to prevent gestational diabetes (GDM) have shown the best results when lifestyle measures have been applied early in pregnancy. We aimed to investigate whether first-trimester fasting plasma glucose (FPG) could predict GDM risk and adverse pregnancy outcomes.
Methods: A retrospective analysis of prospectively collected data from singleton pregnancies who were attended at our hospital between 2008 and 2018 (n = 27,198) was performed. We included patients with a recorded first-trimester FPG and complete pregnancy data (n = 6845). Patients under 18, with pregestational diabetes or reproductive techniques, were excluded. First-trimester FPG was evaluated as a continuous variable and divided into quartiles. GDM was diagnosed by NDDG criteria. The relationship between first- and second-trimester glucose > 92 mg/dL was also investigated. The relationship between FPG and pregnancy outcomes was assessed in 6150 patients who did not have GDM.
Results: Maternal age was 34.2 ± 3.9 years, BMI 23.1 ± 3.7 kg/m and mean FPG 83.0 ± 7.3 mg/dL. Glucose quartiles were: ≤ 78, 79-83, 84-87 and ≥ 88 mg/dL. First-trimester FPG predicted the risk of GDM (7%, 8%, 10.2% and 16% in each quartile, p < 0.001) and the risk of second-trimester glucose > 92 mg/dL (2.6%, 3.8%, 6.3% and 11.4% in each quartile, p < 0.001). FPG was significantly associated with LGA (8.2%, 9.3%, 10% and 11.7% in each quartile, p = 0.011) but not with other obstetrical outcomes. In a multivariate analysis including age, BMI, tobacco use, number of pregnancies and weight gained during pregnancy, first-trimester FPG was an independent predictor of LGA.
Conclusions: First-trimester FPG is an early marker of GDM and LGA.
Muntean M, Marginean C, Bernad E, Banescu C, Nyulas V, Muntean I Children (Basel). 2025; 12(2).
PMID: 40003257 PMC: 11854160. DOI: 10.3390/children12020155.
Universal screening for hyperglycemia in early pregnancy and the risk of adverse pregnancy outcomes.
Shen L, Zhang S, Wen J, Liu J, Lin X, Zhu C BMC Pregnancy Childbirth. 2025; 25(1):203.
PMID: 40001063 PMC: 11863529. DOI: 10.1186/s12884-025-07253-4.
Lou Y, Chen G, Wang L, Zhao X, Ma J BMC Pregnancy Childbirth. 2025; 25(1):144.
PMID: 39934694 PMC: 11816570. DOI: 10.1186/s12884-025-07241-8.
Inthavong S, Jatavan P, Tongsong T Int J Mol Sci. 2024; 25(21).
PMID: 39519218 PMC: 11545977. DOI: 10.3390/ijms252111666.
Prediction of gestational diabetes mellitus by multiple biomarkers at early gestation.
Yang M, Zhang L, Wang W, Huang R, He H, Zheng T BMC Pregnancy Childbirth. 2024; 24(1):601.
PMID: 39285345 PMC: 11406857. DOI: 10.1186/s12884-024-06651-4.